<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04202406</url>
  </required_header>
  <id_info>
    <org_study_id>CEBD-CU-2019-03-13</org_study_id>
    <nct_id>NCT04202406</nct_id>
  </id_info>
  <brief_title>Preoperative Acetaminophen- Caffeine- Codeine Combination and Anaesthetic Success in Patients With Acute Pulpitis</brief_title>
  <official_title>Effect of Preoperative Acetaminophen-Codeine-Caffeine Combination on Inferior Alveolar Nerve Block Success in Patients With Symptomatic Irreversible Pulpitis: Randomized Double-blind Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate the effect of preoperative administration of
      acetaminophen- codeine -caffeine combination on the success of the inferior alveolar nerve
      block versus bacetaminophen alone or placebo in patients with symptomatic irreversible
      pulpitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After ensuring eligibility, patients will be given premedication 1hr before treatment,which
      will be done in single visit.

      After 1 hour, Pretreatment pain &quot;pain after administration of analgesic or placebo&quot; will be
      recorded using 0-10 numerical rating scale (NRS) .

      Local anesthesia will, then, be done through inferior alveolar nerve block using 1.8 ml
      Mepivacaine.

      The teeth will be isolated using rubber dam and access cavity will be prepared using #2
      high-speed round bur.

      The patients will be asked to rate their pain on the NRS. The degree of pain during access
      preparation and/or instrumentation will be recorded.

      Success will be defined as no pain or mild pain during endodontic access preparation and/or
      instrumentation. Any pain more than no pain or mild pain will considered a failure.

      Postoperative pain will be recorded at 6,12,24,and 48 hours.

      The patients will be instructed to return after 2 days to complete the treatment procedures
      by placing a permanent restoration.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2020</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Success of mandibular inferior alveolar nerve block anesthesia during access and instrumentation.</measure>
    <time_frame>During the treatment</time_frame>
    <description>Will be recorded by 11 point NRS consisting of numbers from 0 through 10. 0: reading represents &quot;no pain&quot; 1-3 : readings represent &quot;mild pain&quot; 4-6 : readings represent &quot;moderate pain&quot; 7-10 : readings represent &quot;severe pain&quot; 0: reading represents &quot;no pain&quot; 1-3 : readings represent &quot;mild pain&quot; 4-6 : readings represent &quot;moderate pain&quot; 7-10 : readings represent &quot;severe pain&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain at 6h</measure>
    <time_frame>6 hours</time_frame>
    <description>Will be recorded by 11point NRS 0: reading represents &quot;no pain&quot; 1-3 : readings represent &quot;mild pain&quot; 4-6 : readings represent &quot;moderate pain&quot; 7-10 : readings represent &quot;severe pain&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain at 12h</measure>
    <time_frame>12 hours</time_frame>
    <description>Will be recorded by 11point NRS 0: reading represents &quot;no pain&quot; 1-3 : readings represent &quot;mild pain&quot; 4-6 : readings represent &quot;moderate pain&quot; 7-10 : readings represent &quot;severe pain&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain at 24h</measure>
    <time_frame>24 hours</time_frame>
    <description>Will be recorded by 11point NRS 0: reading represents &quot;no pain&quot; 1-3 : readings represent &quot;mild pain&quot; 4-6 : readings represent &quot;moderate pain&quot; 7-10 : readings represent &quot;severe pain&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain at 48h</measure>
    <time_frame>48 hours</time_frame>
    <description>Will be recorded by 11point NRS 0: reading represents &quot;no pain&quot; 1-3 : readings represent &quot;mild pain&quot; 4-6 : readings represent &quot;moderate pain&quot; 7-10 : readings represent &quot;severe pain&quot;</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">69</enrollment>
  <condition>Symptomatic Irreversible Pulpitis</condition>
  <arm_group>
    <arm_group_label>Acetaminophen, codeine,and caffeine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral single dose of Combination of 1000mg acetaminophen- 16mg codeine- 60mg caffeine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acetaminophen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral single dose of 1000mg acetaminophen.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Maize starch.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen and codeine and caffeine</intervention_name>
    <description>The patient will receive pretreatment oral single dose of Combination of 1000mg acetaminophen- 16mg codeine- 60mg caffeine 1 hour before treatment.</description>
    <arm_group_label>Acetaminophen, codeine,and caffeine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>The patient will receive pretreatment oral single dose of 1000mg acetaminophen alone 1 hour before treatment.</description>
    <arm_group_label>Acetaminophen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>The patient will receive placebo (starch) 1hour before treatment.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients aging between 18-50 years old.

          2. Patients with mandibular molar with symptomatic irreversible pulpitis.

          3. Systemically- healthy patients.

          4. Patients who agree to attend for recall appointments and provide a written consent.

        Exclusion Criteria:

          1. Pregnant or lactating female patients.

          2. Patients had allergies to any of test medications.

          3. Patients had taken analgesics medication within the last 6 hours.

          4. Moderate or severe marginal periodontitis i.e. pocket probe&gt;3mm.

          5. Non-restorable teeth, teeth with necrotic pulp, pulp polyp, tooth tender to
             percussion, root resorption or root canal calcification, periapical disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alaa M. Morsi</last_name>
    <role>Principal Investigator</role>
    <affiliation>faculty of dentistry Cairo university</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alaa M. Morsi, B.D.S</last_name>
    <phone>01092595968</phone>
    <phone_ext>+2</phone_ext>
    <email>alaa.morsi@dentistry.cu.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ghada E. Eid, Ph.D</last_name>
    <phone>01001266608</phone>
    <phone_ext>+2</phone_ext>
    <email>ghada.eid@dentistry.cu.edu.eg</email>
  </overall_contact_backup>
  <reference>
    <citation>Ianiro SR, Jeansonne BG, McNeal SF, Eleazer PD. The effect of preoperative acetaminophen or a combination of acetaminophen and Ibuprofen on the success of inferior alveolar nerve block for teeth with irreversible pulpitis. J Endod. 2007 Jan;33(1):11-4.</citation>
    <PMID>17185119</PMID>
  </reference>
  <reference>
    <citation>Cohen HP, Cha BY, Sp√•ngberg LS. Endodontic anesthesia in mandibular molars: a clinical study. J Endod. 1993 Jul;19(7):370-3.</citation>
    <PMID>8245762</PMID>
  </reference>
  <reference>
    <citation>Simpson M, Drum M, Nusstein J, Reader A, Beck M. Effect of combination of preoperative ibuprofen/acetaminophen on the success of the inferior alveolar nerve block in patients with symptomatic irreversible pulpitis. J Endod. 2011 May;37(5):593-7. doi: 10.1016/j.joen.2011.02.015. Epub 2011 Mar 22.</citation>
    <PMID>21496654</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>December 16, 2019</study_first_submitted>
  <study_first_submitted_qc>December 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2019</study_first_posted>
  <last_update_submitted>July 13, 2020</last_update_submitted>
  <last_update_submitted_qc>July 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Alaa Mohammed Abdallah Morsi</investigator_full_name>
    <investigator_title>Post graduate student, Department of Endodontics, Faculty of Dentistry,Cairo University</investigator_title>
  </responsible_party>
  <keyword>Postoperative pain</keyword>
  <keyword>Paracetamol</keyword>
  <keyword>Placebo</keyword>
  <keyword>Single visit root canal treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulpitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Codeine</mesh_term>
    <mesh_term>Caffeine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

